Raj Prabhakar
Corporate Officer/Principal bei ROCKET PHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Profil
Raj Prabhakar is currently the Chief Business Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. Prior to his current position, he held the role of Executive Director-Business Development at Imunon, Inc. from 2004 to 2015.
Following that, he served as the Senior Vice President-Business Development at Caladrius Biosciences, Inc. from 2015 to 2017.
Mr. Prabhakar completed his undergraduate studies at Massachusetts Institute of Technology and holds an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
24.04.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Raj Prabhakar
Unternehmen | Position | Beginn |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2017 |
Ehemalige bekannte Positionen von Raj Prabhakar
Unternehmen | Position | Ende |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01.10.2017 |
IMUNON, INC. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Raj Prabhakar
Massachusetts Institute of Technology | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IMUNON, INC. | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |